Search results
Results from the WOW.Com Content Network
Menotropin (also called human menopausal gonadotropin or hMG) is a hormonally active medication for the treatment of fertility disturbances. Frequently the plural is used as the medication is a mixture of gonadotropins. Menotropins are extracted from the urine of postmenopausal women. [1]
A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones. [1] They are used for a variety of indications including in fertility medicine and to lower sex hormone levels in the treatment of hormone-sensitive cancers such as prostate cancer and breast cancer, certain gynecological disorders like heavy periods and endometriosis ...
Preparations of follicle-stimulating hormone (FSH) mainly include those derived from the urine of menopausal women, as well as recombinant preparations. The recombinant preparations are more pure and more easily administered, but they are more expensive.
The average age for menopause, when your periods stop permanently, is 52, according to the U.S. Office on Women's Health. Menopause is reached after it has been a full year since your last period.
Yet obesity rates remain similar for both men and women at 43% and 42%, respectively, according to U.S. government data. "This chronic disease does not discriminate by gender," a Lilly ...
ATC code G03 Sex hormones and modulators of the genital system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
GnRH modulators affect the secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn affects the gonads, influencing their function and hence fertility as well as the production of sex steroids, including that of estradiol and progesterone in women and of testosterone in men.
A national study found that women who exercised regularly — at least 2½ hours of moderate exercise or 75 minutes of vigorous exercise per week — had a 24% lower risk of dying over the study ...